Home › Companies › Biohaven Ltd. › 2025-2026

Biohaven Ltd. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Biohaven Ltd.’s Form 8-K, filed 2026-05-04 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 7Reported items
  • 273Asset managers
  • 1,270Fund votes
  • 2026-04-28Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Biohaven Ltd. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Biohaven Ltd.

These tallies are Biohaven Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-04 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Biohaven Ltd. — official shareholder meeting results, meeting held 2026-04-28
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Proposal No. 1(a): Michael T. Heffernan 76,133,74615,092,6651,984,918 ---- Majority: yes
Elect Director: Proposal No. 1(b): Irina Antonijevic, M.D., Ph.D. 76,612,01714,616,1151,983,197 ---- Majority: yes
Elect Director: Proposal No. 1(c): Robert J. Hugin 76,597,70714,626,1511,987,471 ---- Majority: yes
Elect Director: Ratification of appointment of Ernst & Young LLP 123,723,636214,1231,410,634 ---- Majority: yes
Elect Director: Non-binding vote on the compensation of the Company's named executive officers 87,521,6204,202,8831,486,826 ---- Majority: yes

Source: Biohaven Ltd., Form 8-K, filed with the SEC on 2026-05-04 — read the filing on EDGAR.

How asset managers voted at the Biohaven Ltd. 2025-2026 meeting

Each item below shows how the 273 asset managers that disclosed a Biohaven Ltd. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Biohaven Ltd.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. A non-binding advisory vote on the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 87,521,620AGAINST: 4,202,883

Biohaven Ltd.’s own tally for this item (“Elect Director: Non-binding vote on the compensation of the Company's named executive officers”): 87,521,620 for, 4,202,883 against, per its Form 8-K filed 2026-05-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 150,506,490 outstanding shares: 58% for, 3% against (61% of the company cast a for/against vote).

The 269 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 95%
FOR: 94.9%AGAINST: 4.3%ABSTAIN: 0.8%
Largest asset managers voting on “A non-binding advisory vote on the compensation of the Company's named executive officers.” at Biohaven Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Janus Henderson33,681,00740,486 00For
1919 Investment Counsel, LLC9,793,5880 00For
BlackRock9,725,61320,341 00For
MONTANOVA CAPITAL, LLC8,597,6490 00For
Fidelity6,516,6960 00For
State Street5,398,86922,899 00For
JANUS INVESTMENT FUND5,006,8960 00For
Vanguard4,407,22812,377 20For
T. Rowe Price4,359,2770 00For
GEODE CAPITAL MANAGEMENT, LLC2,465,8610 00For
Capital Group1001,832,792 00Against
Charles Schwab1,724,3060 00For
DE Shaw1,605,1530 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.1,500,0000 00For
AQR1,465,3240 00For
Cormorant Asset Management, LP1,440,9950 00For
Capital Research Global Investors01,332,792 00Against
Two Sigma1,067,2790 00For
Simplify Exchange Traded Funds1,038,3650 00For
DAFNA Capital Management LLC845,7350 00For
Nuveen840,6690 00For
TIAA826,6900 00For
Northern Trust729,15014,372 00For
5AM Venture Management, LLC738,9720 00For
Kynam Capital Management, LP00 702,8840Abstain

Showing the 25 largest of 269 asset managers. See all 269 in the interactive database.

2. Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D.

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

90% fund support · no official result

FOR 90%10%

The 56 asset managers below cast 90% of the shares they voted on this item FOR (26,362,767 for, 2,794,453 against).

FOR: 26,362,767 (90.4%)AGAINST: 2,794,453 (9.6%)ABSTAIN: 12,535 (0.0%)
Largest asset managers voting on “Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D.,” at Biohaven Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND2,795,3422,211,554 00For
BlackRock4,782,3880 00For
Fidelity4,217,2840 00For
State Street3,582,1130 00For
Vanguard3,469,20180,231 30For
T. Rowe Price1,817,4460 00For
Capital Group1,582,7920 00For
Simplify Exchange Traded Funds1,038,3650 00For
Charles Schwab861,9540 00For
TIAA826,6900 00For
Equitable228,3570 00For
JPMorgan206,9610 00For
QUANTITATIVE MASTER SERIES LLC153,5640 00For
EA Series Trust148,5200 00For
Lincoln Financial99,60719,130 00For
Brighthouse62,83538,653 12,5320For
ProShares094,572 00Against
Goldman Sachs73,2660 00For
Direxion Shares ETF Trust062,516 00Against
John Hancock31,50927,892 00For
AIG/SunAmerica056,465 00Against
Roundhill ETF Trust053,413 00Against
Northern Trust49,3130 00For
Global X43,1640 00For
Northern Lights Fund Trust IV42,5020 00For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

3. Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

90% fund support · no official result

FOR 90%10%

The 56 asset managers below cast 90% of the shares they voted on this item FOR (26,344,014 for, 2,813,206 against).

FOR: 26,344,014 (90.3%)AGAINST: 2,813,206 (9.6%)ABSTAIN: 12,535 (0.0%)
Largest asset managers voting on “Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan” at Biohaven Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND2,795,3422,211,554 00For
BlackRock4,782,3880 00For
Fidelity4,217,2840 00For
State Street3,582,1130 00For
Vanguard3,473,53075,902 30For
T. Rowe Price1,817,4460 00For
Capital Group1,582,7920 00For
Simplify Exchange Traded Funds1,038,3650 00For
Charles Schwab861,9540 00For
TIAA826,6900 00For
Equitable228,3570 00For
JPMorgan206,9610 00For
QUANTITATIVE MASTER SERIES LLC153,5640 00For
EA Series Trust148,5200 00For
Lincoln Financial99,60719,130 00For
Brighthouse62,83538,653 12,5320For
ProShares094,572 00Against
Goldman Sachs73,2660 00For
Direxion Shares ETF Trust062,516 00Against
John Hancock31,50927,892 00For
AIG/SunAmerica056,465 00Against
Roundhill ETF Trust053,413 00Against
Northern Trust49,3130 00For
Global X43,1640 00For
Northern Lights Fund Trust IV42,5020 00For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

4. Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

90% fund support · no official result

FOR 90%10%

The 56 asset managers below cast 90% of the shares they voted on this item FOR (26,367,096 for, 2,790,123 against).

FOR: 26,367,096 (90.4%)AGAINST: 2,790,123 (9.6%)ABSTAIN: 12,535 (0.0%)
Largest asset managers voting on “Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin” at Biohaven Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND2,795,3422,211,554 00For
BlackRock4,782,3880 00For
Fidelity4,217,2840 00For
State Street3,582,1130 00For
Vanguard3,473,53075,901 30For
T. Rowe Price1,817,4460 00For
Capital Group1,582,7920 00For
Simplify Exchange Traded Funds1,038,3650 00For
Charles Schwab861,9540 00For
TIAA826,6900 00For
Equitable228,3570 00For
JPMorgan206,9610 00For
QUANTITATIVE MASTER SERIES LLC153,5640 00For
EA Series Trust148,5200 00For
Lincoln Financial99,60719,130 00For
Brighthouse62,83538,653 12,5320For
ProShares094,572 00Against
Goldman Sachs73,2660 00For
Direxion Shares ETF Trust062,516 00Against
John Hancock31,50927,892 00For
AIG/SunAmerica056,465 00Against
Roundhill ETF Trust053,413 00Against
Northern Trust49,3130 00For
Global X43,1640 00For
Northern Lights Fund Trust IV42,5020 00For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

5. RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR FISCAL YEAR 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 123,723,636AGAINST: 214,123

Biohaven Ltd.’s own tally for this item (“Elect Director: Ratification of appointment of Ernst & Young LLP”): 123,723,636 for, 214,123 against, per its Form 8-K filed 2026-05-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 150,506,490 outstanding shares: 82% for, 0.2% against (82% of the company cast a for/against vote).

The 56 asset managers below cast 100% of the shares they voted on this item FOR (29,157,220 for, 0 against).

FOR 99.9%
FOR: 29,157,220 (100.0%)ABSTAIN: 12,535 (0.0%)
Largest asset managers voting on “RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR FISCAL YEAR 2026.” at Biohaven Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND5,006,8960 00For
BlackRock4,782,3880 00For
Fidelity4,217,2840 00For
State Street3,582,1130 00For
Vanguard3,549,4320 30For
T. Rowe Price1,817,4460 00For
Capital Group1,582,7920 00For
Simplify Exchange Traded Funds1,038,3650 00For
Charles Schwab861,9540 00For
TIAA826,6900 00For
Equitable228,3570 00For
JPMorgan206,9610 00For
QUANTITATIVE MASTER SERIES LLC153,5640 00For
EA Series Trust148,5200 00For
Lincoln Financial118,7370 00For
Brighthouse101,4880 12,5320For
ProShares94,5720 00For
Goldman Sachs73,2660 00For
Direxion Shares ETF Trust62,5160 00For
John Hancock59,4010 00For
AIG/SunAmerica56,4650 00For
Roundhill ETF Trust53,4130 00For
Northern Trust49,3130 00For
Global X43,1640 00For
Northern Lights Fund Trust IV42,5020 00For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

6. To approve, on an advisory basis, the compensation of our named executive officers, which we refer to as the Say-on-Pay vote

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 87,521,620AGAINST: 4,202,883

Biohaven Ltd.’s own tally for this item (“Elect Director: Non-binding vote on the compensation of the Company's named executive officers”): 87,521,620 for, 4,202,883 against, per its Form 8-K filed 2026-05-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 150,506,490 outstanding shares: 58% for, 3% against (61% of the company cast a for/against vote).

The 2 asset managers below cast 96% of the shares they voted on this item FOR (418,470 for, 19,214 against).

FOR 95%
FOR: 418,470 (95.4%)AGAINST: 19,214 (4.4%)NOT VOTED: 852 (0.2%)
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers, which we refer to as the S” at Biohaven Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fiera Capital Corp418,47019,214 00For
National Philanthropic Trust00 00Not Voted

7. SAY ON PAY

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

95% Majority: yes · of votes cast

FOR 95%
FOR: 87,521,620AGAINST: 4,202,883

Biohaven Ltd.’s own tally for this item (“Elect Director: Non-binding vote on the compensation of the Company's named executive officers”): 87,521,620 for, 4,202,883 against, per its Form 8-K filed 2026-05-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 150,506,490 outstanding shares: 58% for, 3% against (61% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (2 for, 0 against).

FOR 100%
FOR: 2 (100.0%)
Largest asset managers voting on “SAY ON PAY” at Biohaven Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower20 00For
Ikarian Capital, LLC00 00--

Largest Biohaven Ltd. shareholders voting in 2025-2026

Ranked by the number of Biohaven Ltd. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 150,506,490 shares outstanding at the time of that meeting.

Top Biohaven Ltd. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Janus Henderson 22.41%
21919 Investment Counsel, LLC 6.51%
3BlackRock 6.48%
4MONTANOVA CAPITAL, LLC 5.71%
5Fidelity 4.33%
6State Street 3.60%
7JANUS INVESTMENT FUND 3.33%
8Vanguard 2.94%
9T. Rowe Price 2.90%
10GEODE CAPITAL MANAGEMENT, LLC 1.64%

Reported Biohaven Ltd. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Biohaven Ltd. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 7.46% 13F
Suvretta Capital Management, LLC 6.83% DEF14A
John Childs 6.69% DEF14A
JANUS HENDERSON GROUP Ltd. 5.70% 13G
Woodline Partners LP 5.09% 13G
State Street 4.40% 13F
Vlad Coric, M.D. 3.64% DEF14A
Vanguard Group 2.92% 13F
D.E. Shaw 1.89% 13F
Goldman Sachs 1.67% 13F

Percentages above are of 150,506,490 shares outstanding, as reported by Biohaven Ltd. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Biohaven Ltd.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Biohaven Ltd.'s shareholder meeting held 2026-04-28, in the 2025-2026 proxy season, 273 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,270 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote on the compensation of the Company's named executive officers. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Biohaven Ltd.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-04.

Biohaven Ltd. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).